2004N-0330 - Joint Meeting of the Psychopharmacologic Drugs Advisory Committee and the Pediatric Advisory Committee
FDA Comment Number : EC5
Submitter : Ms. Darcy Gruttadaro Date & Time: 08/30/2004 02:08:56
Organization : National Alliance for the Mentally Ill (NAMI)
Consumer Group
Category :
Issue Areas/Comments
GENERAL
GENERAL
Please find attached the following:

NAMI Statement of Kenneth Duckworth, M.D. On Behalf of NAMI (The National Alliance for the Mentally Ill)Before the Food and Drug Administration Psychopharmacologic Drugs Advisory Committee and the Pediatric Subcommittee of the Anti-Infective Drugs Advisory Committee September 13, 2004

The NAMI Policy Research Institute Task Force Report, "Children and Psychotropic Medications" (Please circulate to all committee members for review).

A Press Release regarding the release of the NAMI Policy Research Institute Task Force Report, "Children and Psychotropic Medications"